4D Molecular Therapeutics (FDMT) Treasury Shares (2019 - 2026)
4D Molecular Therapeutics' (FDMT) quarterly Treasury Shares came in at $1.6 million in Q1 2026, up 113.08% year-on-year from $748380.0 in Q1 2025, and up 114.11% on a QoQ basis from $744770.0 in Q4 2025.
4D Molecular Therapeutics (FDMT) Treasury Shares (2019 - 2026) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 6 years of Treasury Shares data on file, last reported at $1.6 million in Q1 2026.
- On a quarterly basis, Treasury Shares rose 113.08% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 113.08% increase from a year earlier, with the FY2025 full-year figure at $744770.0, up 105.74% from the prior year.
- Treasury Shares for Q1 2026 stood at $1.6 million, up from $744770.0 in the prior quarter.
- Over the last five years, Treasury Shares for FDMT reached as high as $1.6 million in Q1 2026 and fell as low as $181181.0 in Q4 2023.
- Historically, Treasury Shares has averaged $585078.7 across 4 years, with a median of $530008.0 in 2024.
- Across the five-year window, Treasury Shares surged 99.8% in 2024 and surged 256.54% in 2025, its largest moves.
- Year by year, Treasury Shares stood at $181181.0 in 2023, then surged by 99.8% to $361997.0 in 2024, then soared by 105.74% to $744770.0 in 2025, then soared by 114.11% to $1.6 million in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $1.6 million in Q1 2026, $744770.0 in Q4 2025, and $698019.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | 4D Molecular Therapeutics | 706.51 Mn | 315.62 Mn | - | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59 Mn |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 744,770.00 |
| Dec 31, 2025 | 744,770.00 |
| Sep 30, 2025 | 698,019.00 |
| Sep 30, 2025 | 698,019.00 |
| Jun 30, 2025 | 725,101.00 |
| Jun 30, 2025 | 725,101.00 |
| Mar 31, 2025 | 748,380.00 |
| Mar 31, 2025 | 748,380.00 |
| Dec 31, 2024 | 361,997.00 |
| Dec 31, 2024 | 361,997.00 |
| Sep 30, 2024 | 328,667.00 |
| Sep 30, 2024 | 328,667.00 |
| Jun 30, 2024 | 258,117.00 |
| Jun 30, 2024 | 258,117.00 |
| Mar 31, 2024 | 209,900.00 |
| Mar 31, 2024 | 209,900.00 |
| Dec 31, 2023 | 181,181.00 |
| Dec 31, 2023 | 181,181.00 |